跳至主要内容
临床试验/NCT02957305
NCT02957305已完成4 期

Comparison Between 400 µg or 200 µg of Misoprostol for Cervical Dilatation in 1st Trimester Miscarriage - A Clinical Trial

Hospital de Clinicas de Porto Alegre1 个研究点 分布在 1 个国家目标入组 211 人开始时间: 2016年12月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
211
试验地点
1
主要终点
Number of Participants Who Required Cervix Dilation at Initiation of the Manual Vacuum Aspiration

研究概览

简要总结

Local current protocol for cervical ripening in 1st trimester miscarriage recommends 400 µg of misoprostol intravaginally 3 hours before uterine evacuation. This regime has been recommended by some international guidelines . So far, there are no recent studies comparing cervical dilatation between 400 µg of misoprostol and a reduced dose (e.g., 200 µg) for 6 hours. If cervical ripening is similar between these two regimens(i.e., 200µg regimen is not inferior to 400µg regimen), costs reductions and lower side effects may be issued without losing quality of cervix dilatation.

详细描述

Miscarriage is defined by the World Health Organization as the interruption of the pregnancy up to 20-23 weeks, or the products of pregnancy weighing less than 500 grams (1). Nearly 15% of known pregnancies end in miscarriage, especially in the first 12 weeks. Estimates indicate that 68000 women die worldwide each year, as a result of unsafe abortions. Abortions are the major cause of maternal death, particularly in Latin America and the Caribbean. In cases of retained and incomplete abortions, uterine emptying is recommended. In the first trimester of pregnancy, either pharmacological or surgical procedure is accepted according to international guidelines.

Pharmacological treatment for uterine evacuation includes the administration of mifepristone and misoprostol or misoprostol alone. Nevertheless, surgical methods have been shown a greater acceptability and patient satisfaction due to a reduced incidence of adverse effects. Currently, Manual Vacuum Aspiration (MVA) is the technique recommended by the Brazilian Ministry of Health and the Brazilian Federation of Gynecology and Obstetrics.

MVA should be performed after cervical ripening. This pre-surgical procedure makes the procedure safer and more effective. In Brazil, misoprostol is the most suitable drug to be used in these cases because of its efficacy, ease of use, low cost, stability at room temperature, and availability. Misoprostol is a synthetic prostaglandin E1 analog and can be administered by oral, sublingual, buccal, rectal, and vaginal routes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

Patients, operators and statistical analysis were performed blindly.

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • All patients admitted at the Gynecological emergency Unit at Hospital de Clínicas de Porto Alegre scheduled for uterine evacuation with <12 weeks of gestation.

排除标准

  • patients who do not wish to participate in the project;
  • patients with ectopic pregnancy;
  • patients with comorbidities (heart failure congestive, chronic obstructive pulmonary disease);
  • patients with hypovolemic shock;
  • patients with cervical incompetence;
  • patients with infected miscarriage/abortion (presence of fever, pus from the cervix, leukocytosis [> 14000]);
  • patients with twin pregnancy;
  • patients with Marfan syndrome;
  • patients allergic to misoprostol;
  • patients with coagulopathy;
  • patients with opening of cervical internal os (4 mm of dilatation at the time of consultation);
  • patients with previous surgery of the cervix (conization);
  • patients with concomitant use of IUDs.

研究组 & 干预措施

Misoprostol 400 µg

Active Comparator

Participants received misoprostol 400 µg: 2 tablets of misoprostol (200µg each) introduced into the vagina, at least 6 hours before the Manual Vacuum Aspiration (MVA) procedure.

干预措施: Misoprostol 400mcg Tab (Drug)

Misoprostol 200 µg

Experimental

Participants received misoprostol 200 µg: 1 tablet of misoprostol introduced into the vagina, at least 6 hours before the Manual Vacuum Aspiration procedure.

干预措施: Misoprostol 200mcg Tab (Drug)

结局指标

主要结局

Number of Participants Who Required Cervix Dilation at Initiation of the Manual Vacuum Aspiration

时间窗: baseline at initiation of the Manual Vacuum Aspiration

this outcome identifies patients that had to have a mechanical dilator for opening the cervix to perform appropriate Manual Vacuum Aspiration

次要结局

  • Number of Participants With a Presence of a Uterine Cervical Canal With ≥8 mm of Dilation(Baseline before Manual Vacuum Aspiration procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ricardo Francalacci Savaris

Head of the Gynecologic Emergency Unit

Hospital de Clinicas de Porto Alegre

研究点 (1)

Loading locations...

相似试验